Analyzing the Global Market for Active Pharmaceutical Ingredients

Analyzing the Global Market for Active Pharmaceutical Ingredients

The global market for active pharmaceutical ingredients has been growing steadily in recent years. However, the recent economic recession slowed down the growth of the industry as investments made by the major players went down significantly. Furthermore with a large number of blockbuster drugs going off patent by the end of 2014, there is expected to be a major impact on the global API industry. Revenues of the API markets are likely to be affected as generic drugs take up the market.

The United States remains one of the biggest players in the market, followed closely by China and India. Synthetic pharmaceuticals also continue to dominate the API industry as biotech APIs move up slowly. Major companies such as Teva, Dr Reddy's and Boehringer Ingelheim continue to invest heavily in the API industry and remain the leading players in the global active pharmaceutical ingredient market.

Aruvian Research analyzes the global API industry in its research report Analyzing the Global Market for Active Pharmaceutical Ingredients. The report begins with an introduction to active pharmaceutical ingredients (APIs). An analysis of the global market for APIs includes an industry overview, industry revenues, industry segmentation by the biotech API market and the Synthetic API market and a profile of the High Potency Active Pharmaceutical Ingredient (HPAPAI) Market. We also analyze some of the major impacts on the global API market such as the ongoing and upcoming patent expiries of blockbuster drugs and the impact of the economic recession on the market.

An analysis of the market for APIs in Asia Pacific is carried out through an industry overview, analysis of industry revenues and industry segmentation, the therapeutic applications of APIs in Asia Pacific and the impacts on the industry. Key markets analyzed in Asia Pacific include China, India, Japan and South Korea.

An analysis of the market for APIs in Europe is carried out through an industry overview, analysis of industry revenues and industry segmentation, the therapeutic applications of APIs in Europe and the impacts on the industry. Key markets analyzed in Europe include France, Germany, Italy, Spain and the United Kingdom.

An analysis of the market for APIs in North America is carried out through an industry overview, analysis of industry revenues and industry segmentation, the therapeutic applications of APIs in North America and the impacts on the industry. Key markets analyzed in North America include Canada and the United States.

An analysis of the major industry players such as Teva, Albemarle, Actavis, Boehringer, Cipla and others is carried out through an analysis of their business profile, major products & services, financial analysis and a SWOT analysis. This in-depth report on the global market for Active Pharmaceutical Ingredients from Aruvian Research is a comprehensive profile of this industry.

A. Executive Summary

B. Introduction to Active Pharmaceutical Ingredients

C. Global Market for Active Pharmaceutical Ingredients (APIs)
C.1 Industry Overview
C.2 Industry Revenues
C.3 Industry Segmentation
C.3.1 Biotech API Market
C.3.2 Synthetic API Market
C.4 Brief Profile: High Potency Active Pharmaceutical Ingredients (HPAPIs)

D. Impacts on the Global API Market
D.1 Impact of the Economic Recession
D.2 Impact of Patent Expiries & Growing Uptake of Biologics
D.3 Increased Price Competition & Price Cuts by Governments
D.4 Growing Number of Mergers & Acquisitions & Increased Global Coverage
D.5 Regulatory Framework

E. Market for Active Pharmaceutical Ingredients (APIs) in Asia Pacific
E.1 Industry Overview
E.2 Industry Revenues
E.3 Industry Segmentation
E.3.1 Biotech API Market
E.3.2 Synthetic API Market
E.4 Therapeutic Applications of API in Asia Pacific
E.5 Impacts on the Industry

F. Market for Active Pharmaceutical Ingredients (APIs) in China
F.1 Industry Overview
F.2 Industry Revenues
F.3 Industry Segmentation
F.3.1 Biotech API Market
F.3.2 Synthetic API Market

G. Market for Active Pharmaceutical Ingredients (APIs) in India
G.1 Industry Overview
G.2 Industry Revenues
G.3 Industry Segmentation
G.3.1 Biotech API Market
G.3.2 Synthetic API Market

H. Market for Active Pharmaceutical Ingredients (APIs) in Japan
H.1 Industry Overview
H.2 Industry Revenues
H.3 Industry Segmentation
H.3.1 Biotech API Market
H.3.2 Synthetic API Market

I. Market for Active Pharmaceutical Ingredients (APIs) in South Korea
I.1 Industry Overview
I.2 Industry Revenues
I.3 Industry Segmentation
I.3.1 Biotech API Market
I.3.2 Synthetic API Market

J. Market for Active Pharmaceutical Ingredients (APIs) in Europe
J.1 Industry Overview
J.2 Industry Revenues
J.3 Industry Segmentation
J.3.1 Biotech API Market
J.3.2 Synthetic API Market
J.4 Therapeutic Applications of API in Europe
J.5 Impacts on the Industry

K. Market for Active Pharmaceutical Ingredients (APIs) in France
K.1 Industry Overview
K.2 Industry Revenues
K.3 Industry Segmentation
K.3.1 Biotech API Market
K.3.2 Synthetic API Market

L. Market for Active Pharmaceutical Ingredients (APIs) in Germany
L.1 Industry Overview
L.2 Industry Revenues
L.3 Industry Segmentation
L.3.1 Biotech API Market
L.3.2 Synthetic API Market

M. Market for Active Pharmaceutical Ingredients (APIs) in Italy
M.1 Industry Overview
M.2 Industry Revenues
M.3 Industry Segmentation
M.3.1 Biotech API Market
M.3.2 Synthetic API Market

N. Market for Active Pharmaceutical Ingredients (APIs) in Spain
N.1 Industry Overview
N.2 Industry Revenues
N.3 Industry Segmentation
N.3.1 Biotech API Market
N.3.2 Synthetic API Market

O. Market for Active Pharmaceutical Ingredients (APIs) in United Kingdom
O.1 Industry Overview
O.2 Industry Revenues
O.3 Industry Segmentation
O.3.1 Biotech API Market
O.3.2 Synthetic API Market

P. Market for Active Pharmaceutical Ingredients (APIs) in North America
P.1 Industry Overview
P.2 Industry Revenues
P.3 Industry Segmentation
P.3.1 Biotech API Market
P.3.2 Synthetic API Market
P.4 Therapeutic Applications of API in North America
P.5 Impacts on the Industry

Q. Market for Active Pharmaceutical Ingredients (APIs) in Canada
Q.1 Industry Overview
Q.2 Industry Revenues
Q.3 Industry Segmentation
Q.3.1 Biotech API Market
Q.3.2 Synthetic API Market

R. Market for Active Pharmaceutical Ingredients (APIs) in the US
R.1 Industry Overview
R.2 Industry Revenues
R.3 Industry Segmentation
R.3.1 Biotech API Market
R.3.2 Synthetic API Market

S. Major Industry Players
S.1 Albemarle Corporation
S.1.1 Business Profile
S.1.2 Major Products & Services
S.1.3 Financial Analysis
S.1.4 SWOT Analysis
S.2 Actavis Plc
S.2.1 Business Profile
S.2.2 Major Products & Services
S.2.3 Financial Analysis
S.2.4 SWOT Analysis
S.3 BASF SE
S.3.1 Business Profile
S.3.2 Major Products & Services
S.3.3 Financial Analysis
S.3.4 SWOT Analysis
S.4 Boehringer Ingelheim GmbH
S.4.1 Business Profile
S.4.2 Major Products & Services
S.4.3 Financial Analysis
S.4.4 SWOT Analysis
S.5 Bristol-Myers Squibb Company
S.5.1 Business Profile
S.5.2 Major Products & Services
S.5.3 Financial Analysis
S.5.4 SWOT Analysis
S.6 Covidien Plc
S.6.1 Business Profile
S.6.2 Major Products & Services
S.6.3 Financial Analysis
S.6.4 SWOT Analysis
S.7 Hospira Inc
S.7.1 Business Profile
S.7.2 Major Products & Services
S.7.3 Financial Analysis
S.7.4 SWOT Analysis
S.8 Koninklijke DSM N.V.
S.8.1 Business Profile
S.8.2 Major Products & Services
S.8.3 Financial Analysis
S.8.4 SWOT Analysis
S.9 Lonza Group AG
S.9.1 Business Profile
S.9.2 Major Products & Services
S.9.3 Financial Analysis
S.9.4 SWOT Analysis
S.10 Lupin Limited
S.10.1 Business Profile
S.10.2 Major Products & Services
S.10.3 Financial Analysis
S.10.4 SWOT Analysis
S.11 Novartis AG
S.11.1 Business Profile
S.11.2 Major Products & Services
S.11.3 Financial Analysis
S.11.4 SWOT Analysis
S.12 Pfizer Inc
S.12.1 Business Profile
S.12.2 Major Products & Services
S.12.3 Financial Analysis
S.12.4 SWOT Analysis
S.13 Sigma-Aldrich Corporation
S.13.1 Business Profile
S.13.2 Major Products & Services
S.13.3 Financial Analysis
S.13.4 SWOT Analysis
S.14 Teva Pharmaceutical Industries Limited
S.14.1 Business Profile
S.14.2 Major Products & Services
S.14.3 Financial Analysis
S.14.4 SWOT Analysis
S.15 Ampac Fine Chemicals LLC
S.16 Aptuit, Inc
S.17 Aurobindo Pharma
S.18 Biocon Ltd
S.19 Cambrex Corporation
S.20 Cipla Ltd
S.21 Daiichi Fine Chemical Co., Ltd.
S.22 Dishman Pharmaceuticals & Chemicals Ltd.
S.23 Dr. Reddy's Laboratories Limited
S.24 Fabbrica Italiana Sintetici
S.25 Matrix Laboratories Limited/Mylan Inc
S.26 Novasep Holding
S.27 Ranbaxy Laboratories
S.28 Sandoz International GmbH
S.29 Sun Pharmaceutical Industries Limited
S.30 WuXi AppTec, Inc

T. Glossary of Terms

List of Figures

Figure 1: Revenues of the Global Active Pharmaceutical Ingredient (API) Market (in USD Million), 2007-2019
Figure 2: Global API Industry Segmentation by Revenues (%), 2013
Figure 3: Revenues of the Global Biotech API Market (in USD Million), 2007-2019
Figure 4: Share of the Global Biotech API Market by Regions (%), 2013
Figure 5: Share of Revenues of the Global Biotech API Market by Regions (%), 2007-2019
Figure 6: Share of the Global Biotech API Market by Application Sector (%), 2013
Figure 7: Revenues of the Global Biotech API Market by Application Sector (in USD Million), 2007-2019
Figure 8: Revenues of the Global Synthetic API Market (in USD Million), 2007-2019
Figure 9: Share of the Global Synthetic API Market by Regions (%), 2013
Figure 10: Share of Revenues of the Global Synthetic API Market by Regions (%), 2007-2019
Figure 11: Share of the Global Synthetic API Market by Application Sector (%), 2013
Figure 12: Revenues of the Global Synthetic API Market by Application Sector (in USD Million), 2007-2019
Figure 13: Revenues of the Active Pharmaceutical Ingredient (API) Market in Asia Pacific (in USD Million), 2007-2019
Figure 14: Asia Pacific API Industry Segmentation by Revenues (%), 2013
Figure 15: Revenues of the Biotech API Market in Asia Pacific (in USD Million), 2007-2019
Figure 16: Share of the Biotech API Market in Asia Pacific by Countries (%), 2013
Figure 17: Performance & Growth of the Biotech API Market in Asia Pacific (%), 2007-2019
Figure 18: Share of Revenues of the Biotech API Market in Asia Pacific by Countries (%), 2007-2019
Figure 19: Share of the Biotech API Market in Asia Pacific by Application Sector (%), 2013
Figure 20: Revenues of the Biotech API Market in Asia Pacific by Application Sector (in USD Million), 2007-2019
Figure 21: Revenues of the Synthetic API Market in Asia Pacific (in USD Million), 2007-2019
Figure 22: Share of the Synthetic API Market in Asia Pacific by Countries (%), 2013
Figure 23: Performance & Growth of the Synthetic API Market in Asia Pacific (%), 2007-2019
Figure 24: Share of Revenues by Countries in Asia Pacific Synthetic API Industry (%), 2007-2019
Figure 25: Share of the Synthetic API Market in Asia Pacific by Application Sector (%), 2013
Figure 26: Revenues of the Synthetic API Market in Asia Pacific by Application Sector (in USD Million), 2007-2019
Figure 27: Revenue Breakdown of the API Market in Asia Pacific by Therapeutic Applications (%), 2013 & 2019
Figure 28: Revenues of the Active Pharmaceutical Ingredient (API) Market in China (in USD Million), 2007-2019
Figure 29: China API Industry Segmentation by Revenues (%), 2007-2019
Figure 30: Revenues of the Biotech API Market in China by Application Sector (in USD Million), 2007-2019
Figure 31: Share of China Biotech API Market by Application Sector (%), 2007-2019
Figure 32: Revenues of the Synthetic API Market in China by Application Sector (in USD Million), 2007-2019
Figure 33: Share of the Synthetic API Market in China by Application Sector (%), 2007-2019
Figure 34: Revenues of the Active Pharmaceutical Ingredient (API) Market in India (in USD Million), 2007-2019
Figure 35: India API Industry Segmentation by Revenues (%), 2007-2019
Figure 36: Revenues of the Biotech API Market in India by Application Sector (in USD Million), 2007-2019
Figure 37: Share of the Biotech API Market in India by Application Sector (%), 2007-2019
Figure 38: Revenues of the Synthetic API Market in India by Application Sector (in USD Million), 2007-2019
Figure 39: Share of the Synthetic API Market in India by Application Sector (%), 2007-2019
Figure 40: Revenues of the API Market in Japan by Industry Segmentation (in USD Million), 2007-2019
Figure 41: Product Type & Revenue Share of the API Market in Japan (%), 2007-2019
Figure 42: Revenues of the Biotech API Market in Japan by Application Sector (in USD Million), 2007-2019
Figure 43: Share of the Biotech API Market in Japan by Application Sector (%), 2007-2019
Figure 44: Revenues of Japan Synthetic API Market by Application Sector (in USD Million), 2007-2019
Figure 45: Share of the Synthetic API Market in Japan by Application Sector (%), 2007-2019
Figure 46: Revenues of the Active Pharmaceutical Ingredient (API) Market in South Korea (in USD Million), 2007-2019
Figure 47: South Korea API Industry Segmentation by Revenues (%), 2007-2019
Figure 48: Revenues of the Biotech API Market in South Korea by Application Sector (in USD Million), 2007-2019
Figure 49: Share of the South Korea Biotech API Market by Application Sector (%), 2007-2019
Figure 50: Revenues of the Synthetic API Market in South Korea by Application Sector (in USD Million), 2007-2019
Figure 51: Share of the Synthetic API Market in South Korea by Application Sector (%), 2007-2019
Figure 52: Revenues of the Europe Active Pharmaceutical Ingredient (API) Market (in USD Million), 2007-2019
Figure 53: European API Industry Segmentation by Revenues (%), 2013
Figure 54: Revenues of the European Biotech API Market (in USD Million), 2007-2019
Figure 55: Share of the European Biotech API Market by Countries (%), 2013
Figure 56: Performance & Growth of the Biotech API Market in Europe (%), 2007-2019
Figure 57: Share of Revenues of the European Biotech API Market by Countries (%), 2007-2019
Figure 58: Share of the European Biotech API Market by Application Sector (%), 2013
Figure 59: Revenues of the European Biotech API Market by Application Sector (in USD Million), 2007-2019
Figure 60: Revenues of the European Synthetic API Market (in USD Million), 2007-2019
Figure 61: Share of the European Synthetic API Market by Countries (%), 2013
Figure 62: Performance & Growth of the Synthetic API Market in Europe (%), 2007-2019
Figure 63: Share of Revenues of the Europe Synthetic API Market by Countries (%), 2007-2019
Figure 64: Share of the European Synthetic API Market by Application Sector (%), 2013
Figure 65: Revenues of the European Synthetic API Market by Application Sector (in USD Million), 2007-2019
Figure 66: Revenue Breakdown of the API Market in Europe by Therapeutic Applications (%), 2013 & 2019
Figure 67: Revenues of the Active Pharmaceutical Ingredient (API) Market in France (in USD Million), 2007-2019
Figure 68: France API Industry Segmentation by Revenues (%), 2007-2019
Figure 69: Revenues of the Biotech API Market in France by Application Sector (in USD Million), 2007-2019
Figure 70: Share of the Biotech API Market in France by Application Sector (%), 2007-2019
Figure 71: Revenues of the Synthetic API Market in France by Application Sector (in USD Million), 2007-2019
Figure 72: Share of the Synthetic API Market in France by Application Sector (%), 2007-2019
Figure 73: Revenues of the Active Pharmaceutical Ingredient (API) Market in Germany (in USD Million), 2007-2019
Figure 74: Revenue Share of the API Market in Germany by Product Type (%), 2007-2019
Figure 75: Revenues of the Biotech API Market in Germany by Application Sector (in USD Million), 2007-2019
Figure 76: Share of the Biotech API Market in Germany by Application Sector (%), 2007-2019
Figure 77: Revenues of the Synthetic API Market in Germany by Application Sector (in USD Million), 2007-2019
Figure 78: Share of the Synthetic API Market in Germany by Application Sector (%), 2007-2019
Figure 79: Revenues of the Active Pharmaceutical Ingredient (API) Market in Italy (in USD Million), 2007-2019
Figure 80: Italy API Industry Segmentation by Revenues (%), 2007-2019
Figure 81: Revenues of the Biotech API Market in Italy by Application Sector (in USD Million), 2007-2019
Figure 82: Share of the Biotech API Market in Italy by Application Sector (%), 2007-2019
Figure 83: Revenues of the Synthetic API Market in Italy by Application Sector (in USD Million), 2007-2019
Figure 84: Share of the Synthetic API Market in Italy by Application Sector (%), 2007-2019
Figure 85: Revenues of the Active Pharmaceutical Ingredient (API) Market in Spain (in USD Million), 2007-2019
Figure 86: Spain API Industry Segmentation by Revenues (%), 2007-2019
Figure 87: Revenues of the Biotech API Market in Spain by Application Sector (in USD Million), 2007-2019
Figure 88: Share of the Biotech API Market in Spain by Application Sector (%), 2007-2019
Figure 89: Revenues of the Synthetic API Market in Spain by Application Sector (in USD Million), 2007-2019
Figure 90: Share of the Synthetic API Market in Spain by Application Sector (%), 2007-2019
Figure 91: Revenues of the Active Pharmaceutical Ingredient (API) Market in the UK (in USD Million), 2007-2019
Figure 92: UK API Industry Segmentation by Revenues (%), 2007-2019
Figure 93: Revenues of the Biotech API Market in UK by Application Sector (in USD Million), 2007-2019
Figure 94: Share of the Biotech API Market in UK by Application Sector (%), 2007-2019
Figure 95: Revenues of the Synthetic API Market in the UK by Application Sector (in USD Million), 2007-2019
Figure 96: Share of the Synthetic API Market in UK by Application Sector (%), 2007-2019
Figure 97: Revenues of the Active Pharmaceutical Ingredient (API) Market in North America (in USD Million), 2007-2019
Figure 98: Industry Segmentation of the Active Pharmaceutical Ingredients (API) Market in North America by Revenues (%), 2007-2019
Figure 99: Revenues of the Biotech API Market in North America (in USD Million), 2007-2019
Figure 100: Share of the Biotech API Market in North America by Countries (%), 2013
Figure 101: Performance & Growth of the Biotech API Market in North America (%), 2007-2019
Figure 102: Share of Revenues of the Biotech API Market in North America by Countries (%), 2007-2019
Figure 103: Share of the Biotech API Market in North America by Application Sector (%), 2013
Figure 104: Revenues of the Biotech API Market in North America by Application Sector (in USD Million), 2007-2019
Figure 105: Revenues of the Synthetic API Market in North America (in USD Million), 2007-2019
Figure 106: Share of the Synthetic API Market in North America by Countries (%), 2013
Figure 107: Performance & Growth of the Synthetic API Market in North America (%), 2007-2019
Figure 108: Share of Revenues by Countries in North America Synthetic API Industry (%), 2007-2019
Figure 109: Share of the Synthetic API Market in North America by Application Sector (%), 2013
Figure 110: Revenues of the Synthetic API Market in North America by Application Sector (in USD Million), 2007-2019
Figure 111: Revenue Breakdown of the API Market in North America by Therapeutic Applications (%), 2013 & 2019
Figure 112: Revenues of the API Market in Canada by Industry Segmentation (in USD Million), 2007-2019
Figure 113: Revenue Share of the API Market in Canada by Industry Segments (%), 2007-2019
Figure 114: Revenues of the Canada Biotech API Market by Application Sector (in USD Million), 2007-2019
Figure 115: Share of the Canada Biotech API Market by Application Sector (%), 2007-2019
Figure 116: Revenues of the Canada Synthetic API Market by Application Sector (in USD Million), 2007-2019
Figure 117: Share of the Canada Synthetic API Market by Application Sector (%), 2007-2019
Figure 118: Revenues of the API Market in the US by Industry Segmentation (in USD Million), 2007-2019
Figure 119: Revenue Share of the API Market in the US by Industry Segments (%), 2007-2019
Figure 120: Revenues of the US Biotech API Market by Application Sector (in USD Million), 2007-2019
Figure 121: Share of the US Biotech API Market by Application Sector (%), 2007-2019
Figure 122: Revenues of the US Synthetic API Market by Application Sector (in USD Million), 2007-2019
Figure 123: Share of the US Synthetic API Market by Application Sector (%), 2007-2019
Figure 124: Financial Performance of Albemarle Corporation (in USD Million), 2009-2013
Figure 125: Financial Performance of Actavis Plc (in USD Million), 2009-2013
Figure 126: Financial Performance of BASF SE (in EUR Million), 2009-2013
Figure 127: Financial Performance of Bristol-Myers Squibb Company (in USD Million), 2009-2013
Figure 128: Financial Performance of Covidien Plc (in USD Million), 2009-2013
Figure 129: Financial Performance of Hospira Inc (in USD Million), 2009-2013
Figure 130: Financial Performance of Koninklijke DSM N.V. (in EUR Million), 2009-2013
Figure 131: Financial Performance of Lonza Group (in CHF Million), 2009-2013
Figure 132: Financial Performance of Lupin Limited (in INR Million), 2010-2014
Figure 133: Financial Performance of Novartis AG (in USD Million), 2009-2013
Figure 134: Financial Performance of Pfizer Inc (in USD Million), 2009-2013
Figure 135: Financial Performance of Sigma-Aldrich Corporation (in USD Million), 2009-2013
Figure 136: Financial Performance of Teva Pharmaceutical Industries Limited (in USD Million), 2009-2013

List of Tables

Table 1: Revenues of the Global Active Pharmaceutical Ingredient (API) Market (in USD Million), 2007-2019
Table 2: Revenues of the Global Biotech API Market (in USD Million), 2007-2019
Table 3: Revenues of the Global Biotech API Market by Application Sector (in USD Million), 2007-2019
Table 4: Revenues of the Global Synthetic API Market (in USD Million), 2007-2019
Table 5: Revenues of the Global Synthetic API Market by Application Sector (in USD Million), 2007-2019
Table 6: Revenues of the Active Pharmaceutical Ingredient (API) Market in Asia Pacific (in USD Million), 2007-2019
Table 7: Revenues of the Biotech API Market in Asia Pacific (in USD Million), 2007-2019
Table 8: Revenues of the Biotech API Market in Asia Pacific by Application Sector (in USD Million), 2007-2019
Table 9: Revenues of the Synthetic API Market in Asia Pacific (in USD Million), 2007-2019
Table 10: Share of Revenues by Countries in Asia Pacific Synthetic API Industry (in USD Million), 2007-2019
Table 11: Revenues of the Synthetic API Market in Asia Pacific by Application Sector (in USD Million), 2007-2019
Table 12: Revenue Breakdown of the API Market in Asia Pacific by Therapeutic Applications (%), 2013 & 2019
Table 13: Revenues of the Active Pharmaceutical Ingredient (API) Market in China (in USD Million), 2007-2019
Table 14: Revenues of the Biotech API Market in China by Application Sector (in USD Million), 2007-2019
Table 15: Revenues of the Synthetic API Market in China by Application Sector (in USD Million), 2007-2019
Table 16: Revenues of the Active Pharmaceutical Ingredient (API) Market in India (in USD Million), 2007-2019
Table 17: Revenues of the Biotech API Market in India by Application Sector (in USD Million), 2007-2019
Table 18: Revenues of the Synthetic API Market in India by Application Sector (in USD Million), 2007-2019
Table 19: Revenues of the API Market in Japan by Industry Segmentation (in USD Million), 2007-2019
Table 20: Revenues of the Biotech API Market in Japan by Application Sector (in USD Million), 2007-2019
Table 21: Revenues of Japan Synthetic API Market by Application Sector (in USD Million), 2007-2019
Table 22: Revenues of the Active Pharmaceutical Ingredient (API) Market in South Korea (in USD Million), 2007-2019
Table 23: Revenues of the Biotech API Market in South Korea by Application Sector (in USD Million), 2007-2019
Table 24: Revenues of the Synthetic API Market in South Korea by Application Sector (in USD Million), 2007-2019
Table 25: Revenues of the Europe Active Pharmaceutical Ingredient (API) Market (in USD Million), 2007-2019
Table 26: Revenues of the European Biotech API Market (in USD Million), 2007-2019
Table 27: Revenues of the European Biotech API Market by Application Sector (in USD Million), 2007-2019
Table 28: Revenues of the European Synthetic API Market (in USD Million), 2007-2019
Table 29: Revenues of the European Synthetic API Market by Application Sector (in USD Million), 2007-2019
Table 30: Revenue Breakdown of the API Market in Europe by Therapeutic Applications (%), 2013 & 2019
Table 31: Pricing & Reimbursement Mechanism in Top Markets in Europe, 2013
Table 32: Revenues of the Active Pharmaceutical Ingredient (API) Market in France (in USD Million), 2007-2019
Table 33: Revenues of the Biotech API Market in France by Application Sector (in USD Million), 2007-2019
Table 34: Revenues of the Synthetic API Market in France by Application Sector (in USD Million), 2007-2019
Table 35: Revenues of the Active Pharmaceutical Ingredient (API) Market in Germany (in USD Million), 2007-2019
Table 36: Revenues of the Biotech API Market in Germany by Application Sector (in USD Million), 2007-2019
Table 37: Revenues of the Synthetic API Market in Germany by Application Sector (in USD Million), 2007-2019
Table 38: Revenues of the Active Pharmaceutical Ingredient (API) Market in Italy (in USD Million), 2007-2019
Table 39: Revenues of the Biotech API Market in Italy by Application Sector (in USD Million), 2007-2019
Table 40: Revenues of the Synthetic API Market in Italy by Application Sector (in USD Million), 2007-2019
Table 41: Revenues of the Active Pharmaceutical Ingredient (API) Market in Spain (in USD Million), 2007-2019
Table 42: Revenues of the Biotech API Market in Spain by Application Sector (in USD Million), 2007-2019
Table 43: Revenues of the Synthetic API Market in Spain by Application Sector (in USD Million), 2007-2019
Table 44: Revenues of the Active Pharmaceutical Ingredient (API) Market in the UK (in USD Million), 2007-2019
Table 45: Revenues of the Biotech API Market in UK by Application Sector (in USD Million), 2007-2019
Table 46: Revenues of the Synthetic API Market in the UK by Application Sector (in USD Million), 2007-2019
Table 47: Revenues of the Active Pharmaceutical Ingredient (API) Market in North America (in USD Million), 2007-2019
Table 48: Revenues of the Biotech API Market in North America (in USD Million), 2007-2019
Table 49: Revenues of the Biotech API Market in North America by Application Sector (in USD Million), 2007-2019
Table 50: Revenues of the Synthetic API Market in North America (in USD Million), 2007-2019
Table 51: Revenues of the Synthetic API Market in North America by Application Sector (in USD Million), 2007-2019
Table 52: Revenue Breakdown of the API Market in North America by Therapeutic Applications (%), 2013 & 2019
Table 53: Drugs with Patent Expiries till 2017
Table 54: Revenues of the API Market in Canada by Industry Segmentation (in USD Million), 2007-2019
Table 55: Revenues of the Canada Biotech API Market by Application Sector (in USD Million), 2007-2019
Table 56: Revenues of the Canada Synthetic API Market by Application Sector (in USD Million), 2007-2019
Table 57: Revenues of the API Market in the US by Industry Segmentation (in USD Million), 2007-2019
Table 58: Revenues of the US Biotech API Market by Application Sector (in USD Million), 2007-2019
Table 59: Revenues of the US Synthetic API Market by Application Sector (in USD Million), 2007-2019

Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.